Incretin Therapies
Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

Released: February 09, 2024

Jennifer B Green
Jennifer B Green, MD
Carol Hatch Wysham
Carol Hatch Wysham, MD

Activity

Progress
1
Course Completed

In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes:

  • Beneficial effects beyond glycemic control
  • Adverse events and how to manage them
  • Non- or partial responders and the importance of setting expectations with patients
  • Weight rebound when discontinuing therapy
  • Medication access issues related to cost and drug availability